Regenesis Biomedical
AZ - ScottsdaleBiotechnology
Focus: Regenesis Biomedical is a medical device company specializing in energy-based pain management systems, primarily the Provant Therapy System platform for neurological and post-operative indications. The company operates as a focused device manufacturer in the neurology and pain management space.
Profile data last refreshed 1h ago · AI intelligence enriched 1h ago
Open Jobs
0
About Regenesis Biomedical
AI assessmentNot HiringNo open roles listed right now. Follow Regenesis Biomedical to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Regenesis Biomedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
12 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
The Provant Therapy System
Diabetic Foot UlcersClinical Trials (1)
NCT00761176A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers
N/AHelp build intelligence for Regenesis Biomedical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.